Industry News: Volume 2, Issue 2

Medicare Punishes 2,499 Hospitals for High Readmissions By Jordan Rau KHN.com—The federal government’s effort to penalize hospitals for excessive patient readmissions is ending its first decade with Medicare cutting payments to nearly half the nation’s hospitals. In its 10th annual round of penalties, Medicare is reducing its payments to 2,499 hospitals, or 47%

Volume 2, Issue 1: Frank Amato, President and CEO, and Dr. Daniel Alkon, Chief Scientific Advisor, SYNAPS Dx, Discuss First Minimally Invasive Test for Alzheimer’s Disease

Dear Colleagues, Good news for the medical travel community, domestic and international: Medical Travel & Digital Health News (MTDHN) has been accepted as the sponsor of the first “Medical Travel Month” – January 2022 – in the Society for Healthcare Marketing and Development, American Hospital Association’s “2022 Calendar of Health Observances

Spotlight Interview: Frank Amato, President and CEO, SYNAPS Dx, and Dr. Daniel Alkon, Chief Scientific Advisor, SYNAPS Dx

About Frank Amato Frank Amato is CEO and president of SYNAPS Dx. Previously, after two decades in the pharmaceutical and biotech industries, he was president, CEO and director of electroCore, a NASDAQ-traded bioelectronic medicine company focused on treating neurodegenerative conditions. Frank is an accomplished leader with a track record for consistently

Industry News: Volume 2, Issue 1

SYNAPS Dx Completes $10 Million Series A Investment, Accelerates Commercialization of DISCERN: First Minimally Invasive Test for Accurate Diagnosis of Alzheimer’s Disease ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease (AD), announces the close

Volume 1, Issue 23: National Breast Cancer Awareness Month: Liz Cormier-May, CEO, Mammogen, Inc. Discusses Digital Diagnostics for the Early Detection of Breast Cancer in Women

Dear Colleagues, Good news for the medical travel community, domestic and international: Medical Travel & Digital Health News (MTDHN) has been accepted as the sponsor of the first “Medical Travel Month” – January 2022 – in the Society for Healthcare Marketing and Development, American Hospital Association’s “2022 Calendar of Health Observances

Spotlight Interview: Liz Cormier-May, CEO, Mammogen, Inc.

About Elizabeth Cormier-May Liz has been in the biotechnology industry for nearly 20 years, with a focus on early start-ups and company creation.  She started her career as a medicinal chemist for Novartis Institute for Biomedical Research, working in early discovery oncology.  She quickly realized that her ability to create meaningful

Industry News: Volume 1, Issue 23

COVID-19 Cases, Hospitalizations Drop as Poll Shows 20% of Adults Won’t Get Vaccinated By Cecelia Smith-Schoenwalder USNews.com—Nationwide coronavirus cases and hospitalization are down while a poll reports that the percentage of U.S. adults vaccinated or planning to get the shot is the highest it’s been this year. The U.S. is averaging over 110,000

Volume 1, Issue 22: Jeff Gary, CEO, OneShare Health Discusses Faith-Based Healthcare Program Offering Alternative to Costly Health Insurance Plans

Dear Colleagues, In this issue, we speak with Jeff Gary, CEO, OneShare Health, to discuss facilitating medical expenses and offering a unique alternative to costly health insurance plans through a faith-based ministry. This issue also brings you news on the call for pricing transparency and data accessibility, legal action from 24 states

Industry News: Volume 1, Issue 22

Stakeholder panel calls for stronger price transparency enforcement, data accessibility By Dave Muoio FierceHealthcare.com—Many U.S. hospitals have not been publishing their prices, as required by a new law. Now, a panel of researchers, purchasers and regulators is calling for new measures around increasing compliance and the usability of published pricing data.   To